Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

In men with advanced prostate cancer

ASCO: Abiraterone Extends Survival in Metastatic Prostate CA

Side effects noted with use of abiraterone similar to those already found in patients taking the drug
The methylene tetrahydrofolate reductase (MTHFR) gene A1298C polymorphism does not appear to be related to methotrexate efficacy or toxicity in patients with rheumatoid arthritis

MTHFR A1298C Polymorphism Not Linked to MTX Outcomes in RA

No significant link for MTHFR gene A1298C polymorphism with methotrexate efficacy, toxicity
More Americans with HIV are adhering to antiretroviral therapy regimens

Antiretroviral Regimen Adherence Up for Americans With HIV

But too many still stop taking drugs a few years after diagnosis
Capecitabine (Xeloda) can extend the lives of patients with human epidermal growth factor receptor 2-negative breast cancer who have residual invasive disease after receipt of neoadjuvant chemotherapy

Certain Breast CA Patients Benefit From Adjuvant Capecitabine

Capecitabine cut risk of relapse, death by 30 percent over five years, researchers say
A pill containing the antiviral drugs sofosbuvir

Three-Drug Combo Pill Nearly 100 Percent Effective in Curing Hep C

Pill (sofosbuvir, velpatasvir, voxilaprevir) is for patients who have failed with direct-acting antivirals
An appointment-based model which synchronizes medication refills to improve medication adherence is associated with improvement in medication-taking behavior

Medication Adherence Up With Refill Synchronization Model

Improvement in medication-taking behavior; cost savings over one year for HTN, DM, hyperlipidemia
β-blocker use is not associated with reduced mortality after acute myocardial infarction without heart failure or left ventricular systolic dysfunction

β-Blocker Use Not Linked to Reduced Mortality After AMI

No significant difference in mortality for MI patients without HF, LVSD with, without β-blocker use
For patients with high-risk vascular disease

Evacetrapib Appears Futile in High-Risk Vascular Disease

No reduction in primary end point events, including death from cardiovascular causes, MI, stroke
There is a substantial financial burden for Medicare beneficiaries with myeloma who do not receive a low-income subsidy for orally-administered anticancer therapy

High Costs for Myeloma Patients Not Getting Low-Income Subsidy

For those aged 75 to 84 years, LIS receipt linked to increased odds of receiving immunomodulatory drugs
In a case report published online May 23 in the Annals of Internal Medicine

Severe Cutaneous Adverse Effect From Tocilizumab Described

Diffuse, persistent, pruritic maculopapular rash developed 10 days after tocilizumab treatment